A Phase I Pilot Study Of An Antiretroviral Bridging Regimen In Highly Experienced Patients Unable To Achieve Viral Suppression.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lamivudine; Nelfinavir; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
- 11 May 2021 Biomarkers information updated
- 08 Oct 2008 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 26 Jun 2007 Status changed from recruiting to completed.